근시 및 노안 치료 시장 : 치료법별, 적응증별 - 세계 예측(2025-2030년)

The Myopia & Presbyopia Treatment Market was valued at USD 19.47 billion in 2023, expected to reach USD 20.90 billion in 2024, and is projected to grow at a CAGR of 7.84%, to USD 33.04 billion by 2030.

The market for myopia and presbyopia treatments encompasses a range of products and services aimed at correcting these common vision impairments. Myopia (nearsightedness) and presbyopia (age-related farsightedness) require different but sometimes overlapping treatments, including glasses, contact lenses, surgical solutions, and emerging pharmacological approaches. The necessity of these treatments is driven by the increasing prevalence of visual impairments due to factors like aging populations and high screen time among younger demographics. Applications span corrective eyewear, refractive surgery, and innovative interventions such as ortho-k lenses and atropine drops. End-use sectors include optometry clinics, hospitals, specialized eye care centers, and online retail platforms.

Key growth factors include technological advancements in lens materials and surgical techniques, heightened awareness of eye health, and increased affordability of treatments across emerging markets. Opportunities are abundant in the development of non-invasive treatments and digital solutions, like virtual try-on technologies and telehealth services. Companies should focus on personalized treatment plans leveraging AI for diagnosis and tailored solutions. Collaborations with tech firms could also drive growth in smart eyewear designed to reduce digital eye strain.

However, market growth faces limitations such as high costs of advanced surgical options, regulatory challenges, and the widespread availability of low-cost alternatives. Competitive pressures and the complexity of certain treatments also pose challenges. Key areas for innovation include the development of sustainable and biodegradable lens materials, advanced anti-reflective coatings, and further exploration of pharmacological treatments. Research into myopia prevention in children and the link between lifestyle factors and presbyopia progression could unlock new avenues for product development.

Overall, the market is characterized by rapid technological evolution and a competitive landscape. Staying ahead requires continuous innovation, strategic partnerships, and responsiveness to consumer trends and regulatory shifts. Businesses should focus on enhancing patient experiences, affordability, and environmental sustainability to drive growth and meet the evolving demands of a global market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Vision Impairment
  • Rising Geriatric Population
  • Minimally Invasive Alternative for Presbyopia Correction
• Market Restraints
  • Lack of Early Diagnosis and Product Recalls
• Market Opportunities
  • Increasing Market Amalgamation Activity
  • Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
• Market Challenges
  • High Cost Associated with the Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Myopia & Presbyopia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myopia & Presbyopia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myopia & Presbyopia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myopia & Presbyopia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myopia & Presbyopia Treatment Market

A detailed market share analysis in the Myopia & Presbyopia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myopia & Presbyopia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myopia & Presbyopia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myopia & Presbyopia Treatment Market

A strategic analysis of the Myopia & Presbyopia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myopia & Presbyopia Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Myopia & Presbyopia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Contact Lenses, Medication, Prescription Lenses, and Surgery.
• Based on Indication, market is studied across Myopia and Presbyopia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Vision Impairment
    • 5.1.1.2. Rising Geriatric Population
    • 5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of Early Diagnosis and Product Recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing Market Amalgamation Activity
    • 5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
  • 5.1.4. Challenges
    • 5.1.4.1. High Cost Associated with the Treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Myopia & Presbyopia Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Contact Lenses
• 6.3. Medication
• 6.4. Prescription Lenses
• 6.5. Surgery

7. Myopia & Presbyopia Treatment Market, by Indication

• 7.1. Introduction
• 7.2. Myopia
• 7.3. Presbyopia

8. Americas Myopia & Presbyopia Treatment Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Myopia & Presbyopia Treatment Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ABB Optical Group
• 2. AbbVie Inc.
• 3. Accu-Lens Inc.
• 4. Alcon Vision LLC
• 5. Arctic Vision
• 6. Bausch & Lomb Incorporated by Bausch Health Companies Inc.
• 7. Carl Zeiss AG
• 8. CooperVision, Inc.
• 9. Essilor Group
• 10. Euclid Systems Corporation
• 11. Eyenovia, Inc.
• 12. Haag-Streit Group
• 13. Johnson & Johnson Vision
• 14. Menicon Co., Ltd.
• 15. Nidek Co. Ltd.
• 16. Topcon Corporation
• 17. Tylock-George Eye Care & Laser Center
• 18. Ziemer Ophthalmic Systems AG